Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience
Abstract Objectives To assess the occurrence of cardiotoxicity in patients with tumors receiving anthracycline‐based chemotherapy, especially for sarcomas. Methods This study summarized the types and frequency of adverse events (AEs) for three anthracyclines from the FDA adverse event reporting syst...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2023-12-01
|
| Col·lecció: | Cancer Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/cam4.6730 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|